6424-12-0

Basic information

• Product Name: RAFFINOSE UNDECAACETATE
• Synonyms: D-(+)-RAFFINOSE UNDECAACETATE;D-RAFFINOSE UNDECAACETATE;RAFFINOSE UNDECAACETATE;RAFFINOSE UNDECYLACETATE;1,3,4,6-tetra-O-acetyl-beta-D-fructofuranosyl-O-2,3,4,6-tetra-O-acetyl-alpha-D-galactopyranosyl-(1->6)-alpha-D-glucopyranoside triacetate;1-O,3-O,4-O,6-O-Tetraacetyl-β-D-fructofuranosyl 2-O,3-O,4-O-triacetyl-6-O-(2-O,3-O,4-O,6-O-tetraacetyl-α-D-galactopyranosyl)-α-D-glucopyranoside;1-O,3-O,4-O,6-O-Tetraacetyl-β-D-fructofuranosyl 6-O-(2-O,3-O,4-O,6-O-tetraacetyl-α-D-galactopyranosyl)-2-O,3-O,4-O-triacetyl-α-D-glucopyranoside;1-O,3-O,4-O,6-O-Tetraacetyl-β-D-fructofuranosyl 6-O-(2-O,3-O,4-O,6-O-tetraacetyl-α-D-galactopyranosyl)-α-D-glucopyranoside triacetate
• CAS NO: 6424-12-0
• Molecular Formula: C₄₀H₅₄O₂₇
• Molecular Weight: 966.84
• EINECS: 229-181-6
• Product Categories: Carbohydrates;Carbohydrates A to;Carbohydrates P-ZBiochemicals and Reagents;Oligosaccharide
• Mol File: 6424-12-0.mol
• Article Data: 11

Chemical Properties

• Melting Point: 91-92°C
• Boiling Point: 839.6°C at 760 mmHg
• Flash Point: 326.1°C
• Appearance: /
• Density: 1.4g/cm³
• Vapor Pressure: 2.1E-28mmHg at 25°C
• Refractive Index: 1.52
• Storage Temp.: 2-8°C
• CAS DataBase Reference: RAFFINOSE UNDECAACETATE(CAS DataBase Reference)
• NIST Chemistry Reference: RAFFINOSE UNDECAACETATE(6424-12-0)
• EPA Substance Registry System: RAFFINOSE UNDECAACETATE(6424-12-0)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 6424-12-0(Hazardous Substances Data)

Usage

General Description

Raffinose Undecaacetate is a highly acetylated, complex sugar derived from raffinose, a trisaccharide composed of galactose, glucose, and fructose. As a chemical compound, it is known for its sweetening and stabilizing properties, making it useful in various food and pharmaceutical applications. It possesses a slightly sweet taste and is resistant to enzymatic reactions, enabling it to maintain product stability. Its chemical formula is C44H58O23, and it is characterized by flavoring properties and potential health benefits associated with the original raffinose sugar, such as promoting healthy gut bacteria. However, more detailed research is needed to fully understand its biological impacts.

InChI:InChI=1/C40H54O27/c1-16(41)52-12-27-30(56-19(4)44)33(59-22(7)47)35(61-24(9)49)38(64-27)54-13-28-31(57-20(5)45)34(60-23(8)48)36(62-25(10)50)39(65-28)67-40(15-55-18(3)43)37(63-26(11)51)32(58-21(6)46)29(66-40)14-53-17(2)42/h27-39H,12-15H2,1-11H3

Upstream product

• 108-24-7 acetic anhydride 
• 512-69-6 D-raffinose 
• 75-36-5 acetyl chloride 
• 57-50-1 Sucrose 
• 7493-95-0 4-nitrophenyl α-D-galactoside 
• 536-11-8 D-melibiose 
• 6227-50-5 α-D-galactopyranosyl-(1->6)-O-α-D-glucopyranosyl-(1->2)-β-D-fructofuranoside pentahydrate 

Relevant articles and documents

GEL FORMULATIONS FOR IMPROVING IMMUNOTHERAPY

The present invention relates to a composition for use as controlled release of at least one active pharmaceutical ingredient that modulates an immunogenic response in a human or animal body, said composition comprising non-water soluble carbohydrates and wherein the composition is a liquid before administration into the human or animal body and increases in viscosity by more than 1,000 centipoise (cP) after administration.

GEL FORMULATIONS FOR ENHANCING THE EFFECT OF RADIOTHERAPY

The present invention relates to a composition comprising: a. non-water soluble carbohydrates b. a contrast agent for imaging, wherein at least 60% of the contrast agent remains within 10 cm from the injection site after 24h, for use in local co-administration into a human or animal body, and wherein the composition is a liquid before administration into the human or animal body and increases in viscosity by more than 1,000 centipoise (cP) after administration.

Transglycosylations employing recombinant α- And β-galactosidases and novel donor substrates

Recombinant α- and β-galactosidases could be prepared in larger amounts for chemoenzymatic syntheses of glycosylated oligosaccharides relevant in nutrition approaches. α-Galactosidase RafA from Escherichia coli, another thermophilic α-galactosidase AgaB from Geobacillus stearothermophilus KVE39, and also a thermophilic β-galactosidase BglT from Thermus thermophilus TH 125 could be employed in α- and in β-glycosylations, respectively. With model structures as well as sucrose, isomaltitol, and isomaltulose the stereo- and regiospecificities were studied. Further, a number of modified donor structures with structural variation and different leaving groups were synthesized, employed, and compared to classical donors for these transglycosylations.